Results 191 to 200 of about 113,056 (219)

A BSCB‐Penetrating Nanoplatform for Enhanced Luteolin Delivery in PRMT2‐Targeted Epigenetic Therapy of Spinal Cord Injury

open access: yesAdvanced Science, EarlyView.
In this work, MSN‐BO@LUT penetrates the blood‐spinal cord barrier for luteolin delivery in spinal cord injury. The nanodrug suppresses neuroinflammation and promotes functional recovery of the spinal cord. Mechanistically, luteolin targets protein arginine N‐methyltransferase (PRMT2) to decrease toll‐like receptor 4 (TLR4) methylation, thereby ...
Yixuan Wang   +11 more
wiley   +1 more source

Piperazine-Thiourea Hybrids as Novel Antiplatelet Agents Targeting COX-1: Synthesis, <i>in Vitro</i>, and <i>in Silico</i> Evaluation. [PDF]

open access: yesACS Omega
Pereira GRC   +8 more
europepmc   +1 more source

Cyclooxygenases: Structural, Cellular, and Molecular Biology

Annual Review of Biochemistry, 2000
R Michael Garavito   +2 more
exaly  

Home - About - Disclaimer - Privacy